<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01689584</url>
  </required_header>
  <id_info>
    <org_study_id>IC 2011-11</org_study_id>
    <nct_id>NCT01689584</nct_id>
  </id_info>
  <brief_title>COsegregation of VARiants in Panel of Genes</brief_title>
  <acronym>COVAR</acronym>
  <official_title>Study of Family COsegregation of Nucleotide VARiants in the Panel of Genes to Validate Their Use in Genetic Counseling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Curie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Curie</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the COVAR project is to classify reliably a maximum of VUS of the French database&#xD;
      in order to use them for the genetic counseling. The results obtained through this study will&#xD;
      have a major impact on clinical management of the patients and their families conducting in&#xD;
      some cases to propose a prophylactic surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Originally, the COVAR study was designed to explore Variants of unknown biological&#xD;
      significance (VUS) in BRCA1 (BReast Cancer 1) and BRCA2 (BReast Cancer 2) genes, which are&#xD;
      the two major genes identified in hereditary breast and/or ovarian cancers. Since then the&#xD;
      study has evolved, in parallel with the evolution of diagnosis, first introducing the PALB2&#xD;
      (Partner and localizer of BRCA2) gene explored in diagnosis since 2015 and now opening the&#xD;
      study to all the genes of the panels performed in diagnosis in families with a genetic&#xD;
      predisposition syndrome to cancers.&#xD;
&#xD;
      The French UMD (Universal Mutation Database)-BRCA1/2, accredited by the French National&#xD;
      Cancer Institute, collects anonymous results of genetic tests performed by authorized French&#xD;
      laboratories since 1995, giving a real-time vision of families carrying the same VUS. In&#xD;
      september 2011, the French UMD-BRCA1/2 database comprised 706 different variants in 1,300&#xD;
      BRCA1 families and 1,089 different variants in 2,101 BRCA2 families. In April 2021, this&#xD;
      database contained 1,651 different VSU for BRCA1, 3,015 different VUS for BRCA2, 471&#xD;
      different VUS for PALB2, 68 for RAD51C and 66 for RAD51D.&#xD;
&#xD;
      Since 2017, new genes have been explored in the diagnostic setting as they have been reported&#xD;
      as predisposing factors for cancers. This list is constantly evolving (Moretta et al., 2018;&#xD;
      Dhooge et al., 2020). Data collection for these genes is ongoing and a new database (FrOG)&#xD;
      gathering all VUS and mutations identified in the French oncogenetic network has been set up.&#xD;
      We have set up a consortium agreement at the end of 2020. This database gathers to date 12&#xD;
      genes and 11,912 different variants in more than 40,000 French families.&#xD;
&#xD;
      One of the key measurable parameters for classification of VUS as causal mutations is their&#xD;
      co-segregation with the disease. The average size of French families is relatively small, the&#xD;
      information of variant co-segregation limited to one family would not be significant.&#xD;
      However, the compilation of co-segregation results obtained from several families will allow&#xD;
      to obtain more precise and complete estimations of the probability of causality of a given&#xD;
      variant.&#xD;
&#xD;
      The objective of the COVAR study (COsegregation VARiants) is to organize co-segregation&#xD;
      studies of the VUS of the database UMD-BRCA1/2, in order to determine the causal or&#xD;
      non-causal nature of these variants. To organize the variants by their clinical relevance, a&#xD;
      grid with 5 classes has been used: 1=neutral, 2=likely neutral, 3=VUS, 4=likely causal,&#xD;
      5=causal. The VUS of classes 3 and 4 will be candidates to co-segregation studies because&#xD;
      they cannot be used for the genetic counseling.&#xD;
&#xD;
      In the selected families the index case will invite the family members (affected and&#xD;
      unaffected) to provide a sample of salivary fluid to test the presence of the VUS. The&#xD;
      probability that a VUS is causal will be calculated from the cosegregation data using a&#xD;
      Bayesian model. The results will be integrated in the multifactorial model described by D.&#xD;
      Goldgar, model integrating different parameters as amino acid conservation, structural impact&#xD;
      of the variant, co-occurrence with a pathogenic mutation, family history and tumor&#xD;
      characteristics.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2012</start_date>
  <completion_date type="Anticipated">December 2027</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perform the co-segregation analysis of the selected VUS in the families in order to classify the maximum of variants in terms of their probability to be pathogenic</measure>
    <time_frame>up to 15 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>• Propose a standardized method to classify VUS that can be integrated into the already existing classification established in the UMD-BRCA1/2 database, with the main focus on variants of class 4 (probably causal) and class 3 (unknown significance).</measure>
    <time_frame>up to 15 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Maximize the number of VUS (both pathogenic and neutral) having associated recommendations for clinical management of at-risk relatives that can be used to guide genetic counselling.</measure>
    <time_frame>up to 15 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess the penetrance of several class 3 and 4 VUS probably associated with moderate cancer risk, using collected phenotype/genotype data on extended pedigrees.</measure>
    <time_frame>up to 15 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">3500</enrollment>
  <condition>Gene Mutation-Related Cancer</condition>
  <condition>Genetic Predisposition</condition>
  <arm_group>
    <arm_group_label>Covar</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>salivary kit</intervention_name>
    <description>The saliva samples will be made of selected related (DNA).</description>
    <arm_group_label>Covar</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Index cases:&#xD;
&#xD;
          -  A person carrying a gene variant class 3 or 4, present and selected in the families of&#xD;
             national database of genetic group and cancer (GGC Unicancer) which identifies the&#xD;
             variations of all genes from the panel of genes of all French laboratories.&#xD;
&#xD;
          -  Age ≥ 18 years.&#xD;
&#xD;
          -  Signed written inform consent &quot;index case&quot;&#xD;
&#xD;
        Related parties:&#xD;
&#xD;
          -  Any relative of an index case with cancer&#xD;
&#xD;
          -  Any relative without cancer related to an index case, retained by investigators, based&#xD;
             on family structure and degree of related compared to the index case&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Information and signature of the informed consent &quot;selected relatives&quot;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Minors&#xD;
&#xD;
          -  Persons deprived of liberty or under guardianship (including curators).&#xD;
&#xD;
          -  Absence of signed written inform consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique STOPPA-LYONNET, PU-PH</last_name>
    <role>Study Chair</role>
    <affiliation>Institut Curie</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sandrine CAPUTO, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Institut Curie</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandrine CAPUTO, PhD</last_name>
    <phone>33172389367</phone>
    <email>sandrine.caputo@curie.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabelle TURBIEZ, Project Manager</last_name>
    <phone>33147111659</phone>
    <email>isabelle.turbiez@curie.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Curie - Hopital Rene Huguenin</name>
      <address>
        <city>Saint-Cloud</city>
        <state>Haut De Seine</state>
        <zip>92210</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuelle FOURME, PhD</last_name>
      <email>emmanuelle.fourme@curie.fr</email>
    </contact>
    <investigator>
      <last_name>Emmanuelle FOURME, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Curie</name>
      <address>
        <city>Paris</city>
        <state>Ile De France</state>
        <zip>75005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandrine CAPUTO, PhD</last_name>
      <email>sandrine.caputo@curie.fr</email>
    </contact>
    <investigator>
      <last_name>Dominique STOPPA-LYONNET, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Amiens - Hôpital Nord</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles MORIN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gilles MORIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICO - Centre Paul Papin</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier INGSTER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Olivier INGSTER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Angoulème</name>
      <address>
        <city>Angoulême</city>
        <zip>16959</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul GESTA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Paul GESTA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Sainte-Catherine</name>
      <address>
        <city>Avignon</city>
        <zip>84918</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène DREYFUS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hélène DREYFUS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Besançon</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Agnès COLLONGE-RAME, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marie-Agnès COLLONGE-RAME, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie TINAT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Julie TINAT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Bergonié</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginie BUBIEN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Virginie BUBIEN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Jacques Coeur</name>
      <address>
        <city>Bourges</city>
        <zip>18020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle MORTEMOUSQUE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Isabelle MORTEMOUSQUE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Morvan de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc PLANES, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marc PLANES, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre François Baclesse</name>
      <address>
        <city>Caen</city>
        <zip>14076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascaline BERTHET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pascaline BERTHET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Hôtel Dieu</name>
      <address>
        <city>Chambery</city>
        <zip>73011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra FERRER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Sandra FERRER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Jean Perrin</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves-Jean BIGNON, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Yves-Jean BIGNON, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Civil de Colmar</name>
      <address>
        <city>Colmar</city>
        <zip>68024</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Marc LIMACHER</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Marc LIMACHER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence FAIVRE-OLIVIER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Laurence FAIVRE-OLIVIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clémentine LEGRAND, MD</last_name>
    </contact>
    <investigator>
      <last_name>Clémentine LEGRAND, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier La Rochelle-Ré-Aunis</name>
      <address>
        <city>La Rochelle</city>
        <zip>17019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul GESTA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Paul GESTA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Flaubert</name>
      <address>
        <city>Le Havre</city>
        <zip>76083</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elodie LACAZE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Elodie LACAZE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audrey MAILLIEZ, MD</last_name>
    </contact>
    <investigator>
      <last_name>Audrey MAILLIEZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chru Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie LEJEUNE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Sophie LEJEUNE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Dupuytren</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence VENAT-BOUVET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Laurence VENAT-BOUVET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69229</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie GIRAUD, MD</last_name>
    </contact>
    <investigator>
      <last_name>Sophie GIRAUD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Léon Bérard</name>
      <address>
        <city>Lyon</city>
        <zip>69373</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine LASSET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Christine LASSET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hagay SOBOL, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Hagay SOBOL, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU La Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène ZATTARA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hélène ZATTARA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle COUPIER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Isabelle COUPIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Catherine de Sienne</name>
      <address>
        <city>Nantes</city>
        <zip>44202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain LORTHOLARY, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alain LORTHOLARY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Antoine Lacassagne</name>
      <address>
        <city>Nice</city>
        <zip>06189</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Véronique MARI, MD</last_name>
    </contact>
    <investigator>
      <last_name>Véronique MARI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Georges Renon</name>
      <address>
        <city>Niort</city>
        <zip>79021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul GESTA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Paul GESTA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Caremeau</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean CHIESA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean CHIESA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Source</name>
      <address>
        <city>Orléans</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>E COTTEREAU, MD</last_name>
    </contact>
    <investigator>
      <last_name>E COTTEREAU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint-Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanne NETTER-COTI, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jeanne NETTER-COTI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick BENUSIGLIO, MD</last_name>
    </contact>
    <investigator>
      <last_name>Patrick BENUSIGLIO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick BENUSIGLIO, MD</last_name>
    </contact>
    <investigator>
      <last_name>Patrick BENUSIGLIO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint-Louis</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Odile COHEN-HAGUENAUER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Odile COHEN-HAGUENAUER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HEGP</name>
      <address>
        <city>Paris</city>
        <zip>75908</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Laurent PUIG, Phd</last_name>
    </contact>
    <investigator>
      <last_name>Pierre-Laurent PUIG, Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU La Milétrie</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul GESTA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Paul GESTA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Reims</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne DURLACH, MD</last_name>
    </contact>
    <investigator>
      <last_name>Anne DURLACH, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICC Courlancy</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fanny BRAYOTEL, MD</last_name>
    </contact>
    <investigator>
      <last_name>Fanny BRAYOTEL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Jean Godinot</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tan Dat NGUYEN, PHD</last_name>
    </contact>
    <investigator>
      <last_name>Tan Dat NGUYEN, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Eugène Marquis</name>
      <address>
        <city>Rennes</city>
        <zip>35042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louise CRIVELLI, MD</last_name>
    </contact>
    <investigator>
      <last_name>Louise CRIVELLI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle TENNEVET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Isabelle TENNEVET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICO - Centre René Gauducheau</name>
      <address>
        <city>Saint-Herblain</city>
        <zip>44804</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Capucine DELNATTE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Capucine DELNATTE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Saint Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabienne PRIEUR, MD</last_name>
    </contact>
    <investigator>
      <last_name>Fabienne PRIEUR, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut de Cancérologie Strasbourg Europe ICANS</name>
      <address>
        <city>Strasbourg</city>
        <zip>67033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine MAUGARD, MD</last_name>
    </contact>
    <investigator>
      <last_name>Christine MAUGARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de Hautepierre - Hôpital Universitaire</name>
      <address>
        <city>Strasbourg</city>
        <zip>67200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine MAUGARD, MD</last_name>
    </contact>
    <investigator>
      <last_name>Christine MAUGARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Claudius Regaud - IUCT - Oncopole</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence GLADIEFF, MD</last_name>
    </contact>
    <investigator>
      <last_name>Laurence GLADIEFF, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle MORTEMOUSQUE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Isabelle MORTEMOUSQUE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Simone VEIL</name>
      <address>
        <city>Troyes</city>
        <zip>10003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monique MOZELLE-NIVOIX, MD</last_name>
    </contact>
    <investigator>
      <last_name>Monique MOZELLE-NIVOIX, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Valence</name>
      <address>
        <city>Valence</city>
        <zip>26953</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Noëlle BONNET-DUPEYRON, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marie-Noëlle BONNET-DUPEYRON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Alexis Vautrin</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Elisabeth LUPORSI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nancy - Hôpital Brabois</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie MULLER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marie MULLER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier CARON, MD</last_name>
    </contact>
    <investigator>
      <last_name>Olivier CARON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Pointe à Pitre</name>
      <address>
        <city>Pointe à Pitre</city>
        <zip>97110</zip>
        <country>Guadeloupe</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marilyn LACKMY-PORT-LIS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marilyn LACKMY-PORT-LIS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Fort de France</name>
      <address>
        <city>Fort de France</city>
        <zip>97261</zip>
        <country>Martinique</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Odile BERA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Odile BERA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Sud Réunion Saint-Pierre</name>
      <address>
        <city>Saint-Pierre</city>
        <zip>97410</zip>
        <country>Réunion</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanitra RANJATOELINA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hanitra RANJATOELINA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Guadeloupe</country>
    <country>Martinique</country>
    <country>Réunion</country>
  </location_countries>
  <link>
    <url>http://www.umd.be/BRCA1/</url>
    <description>French BRCA1 database</description>
  </link>
  <link>
    <url>http://www.umd.be/BRCA2/</url>
    <description>French BRCA2 database</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 14, 2012</study_first_submitted>
  <study_first_submitted_qc>September 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2012</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>BRCA1</keyword>
  <keyword>BRCA2</keyword>
  <keyword>VUS</keyword>
  <keyword>co-segregation</keyword>
  <keyword>genetic counseling</keyword>
  <keyword>PALB2</keyword>
  <keyword>panel of genes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

